International Ph.D. Program for Cell Therapy and Regeneration Medicine

Organization profile

Organisation profile

The International Ph.D. Program for Cell Therapy and Regeneration Medicine (IPCTRM) begin to recruit students for Fall semester in 2007. The mission of this program is to promote translational medicine and clinical trials of cell/stem cell based therapy. Research at IPCTRM provide diverse research fields, including immune cell applications in cancer treatment; blood and mesenchymal stem cells for regenerative processes, wound healing, graft-versus-host disease, and amyotrophic lateral sclerosis; and drug screening platform with cancer stem cells and disease-specific induced pluripotent stem cells. IPCTRM brings experts and scientists together to facilitate outstanding research not only in basic study but also emphasis on clinical translational medicine, and industrial cell/stem cell product development.

Fingerprint Dive into the research topics where International Ph.D. Program for Cell Therapy and Regeneration Medicine is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Neoplasms Medicine & Life Sciences
Stroke Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cells Chemical Compounds
Taiwan Medicine & Life Sciences
Apoptosis Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2017 2020

新聘教師研究補助

Wong, C.

9/1/198/1/20

Project: B - Project of TMUg - Research Grants for Newly Hired Faculty

搭載山奈酚之生物高分子奈米藥物應用於抑制脈絡膜血管新生之應用研究

Tseng, C.

7/1/192/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

開發利用富含血小板纖維精華支架於一階段式關節軟骨組織之修補與再生

Wong, C.

7/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output 2003 2020

Open Access

Mammalian target of rapamycin and p70S6K mediate thrombin-induced nuclear factor-κB activation and IL-8/CXCL8 release in human lung epithelial cells

Lin, C. H., Shih, C. H., Jiang, C. P., Wen, H. C., Cheng, W. H. & Chen, B. C., Feb 5 2020, In : European Journal of Pharmacology. 868, 172879.

Research output: Contribution to journalArticle

Complement Factor B
Sirolimus
Interleukin-8
Thrombin
Phosphotransferases

NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells

Ho, Y., Wu, C. Y., Chin, Y. T., Li, Z. L., Pan, Y. S., Huang, T. Y., Su, P. Y., Lee, S. Y., Crawford, D. R., Su, K. W., Chiu, H. C., Shih, Y. J., Changou, C. A., Yang, Y. C. S. H., Whang-Peng, J., Chen, Y. R., Lin, H. Y., Mousa, S. A., Davis, P. J. & Wang, K., Feb 2020, In : Food and Chemical Toxicology. 136, 111092.

Research output: Contribution to journalArticle